About the Company
We do not have any company description for Relay Therapeutics, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Relay Therapeutics, Inc.
Raymond James Lowers Relay Therapeutics (RLAY) PT to $19 Following Q2 Results, Strategic Cost Cuts
Relay Therapeutics Inc. (NASDAQ:RLAY) is one of the most promising penny stocks under $5. On August 8, Raymond James lowered ...
Relay Therapeutics (RLAY) Upgraded to Buy: What Does It Mean for the Stock?
Relay Therapeutics, Inc. (RLAY) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings ...
Relay Therapeutics, Inc. (NASDAQ:RLAY) Just Reported And Analysts Have ...
Relay Therapeutics, Inc. (NASDAQ:RLAY) missed earnings with its latest second-quarter results, disappointing overly-optimistic forecasters.
Relay Therapeutics, Inc. (NASDAQ:RLAY) Shares Sold by LPL Financial LLC
Relay Therapeutics, Inc. has a 1-year low of $1.78 and a 1-year high of $10.72. The firm has a market capitalization of $564.51 million, a price-to-earnings ratio of -1.28 and a beta of 1.70.
Barclays Maintains a Buy Rating on Relay Therapeutics (RLAY), Sets a $17 PT
Relay Therapeutics, Inc. (NASDAQ:RLAY) is one of the best strong buy penny stocks to buy now. In a report released on July 29 ...
Relay Therapeutics to Host New Program and Platform Event on June 6 ...
CAMBRIDGE, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading ...
Should You Take Comfort From Insider Transactions At Relay Therapeutics ...
While Relay Therapeutics insiders bought shares during the last year, they didn't sell. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 ...
Relay Therapeutics Announces Updated Data for RLY-2608 + Fulvestrant ...
CAMBRIDGE, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (RLAY) (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining ...
Relay Therapeutics to Announce Fourth Quarter and Full Year 2022 ...
Contact: Caroline Glen 617-370-8837 cglen@relaytx.com Media: Dan Budwick 1AB 973-271-6085 dan@1abmedia.com Source: Relay Therapeutics, Inc. 2023 GlobeNewswire, Inc.
Similar Companies
Loading the latest forecasts...